Barry Meisenberg, MD | Authors


Which Non-Hodgkin's Lymphoma Patients Benefit From ABMT?

February 01, 1996

I would like to take issue with Dr. Bruce Cheson's response to a reader's question on the role of high-dose chemotherapy/autologous bone marrow transplantation (ABMT) in patients with non-Hodgkin's lymphoma (Oncology News International, December, 1995, page 25).